CAS RN: 2375437-25-3
Quinoline, 2-[(4R)-4-(1,1-dimethylethyl)-4,5-dihydro-2-oxazolyl]-5,6,7,8-tetrahydro-
Product Availability
Choose a grade to view its available package options.
1 package records0 with current stock1 grade group
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20250831 |
100mg / 250mg / 1g |
Out of stock |
5-7 business days | Inquiry |
-
Product code:
starshine_CAS2375437-25-3
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
2375437-25-3 / 4-tert-butyl-2-(5,6,7,8-tetrahydroquinolin-2-yl)-4,5-dihydro-1,3-oxazole
Standard CAS: 2375437-25-3
Multi CAS: No
Basic Information
CAS
2375437-25-3
Multi CAS
No
Molecular Formula
C16H22N2O
Molecular Weight
258.360000
Exact Mass
258.173213
SMILES
CC(C)(C)C1COC(=N1)C2=NC3=C(CCCC3)C=C2
InChI
InChI=1S/C16H22N2O/c1-16(2,3)14-10-19-15(18-14)13-9-8-11-6-4-5-7-12(11)17-13/h8-9,14H,4-7,10H2,1-3H3
InChIKey
WZDYWZNSNZZFTP-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
19
Aromatic heavy atom count
6
Fraction Csp3
0.62
Rotatable bonds
1
H-bond acceptors
3
Molar refractivity
76.61
TPSA
34.48
LogP / Solubility
WLOGP
3.15
MLOGP
2.78
XLogP3
3.7
Consensus LogP
3.21
Log S (ESOL)
-3.6
Class (ESOL)
Poorly soluble
Log S (Ali)
-3.95
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-4.08
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.06
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
Yes
Synthetic Accessibility
2